PetroChina's First-Quarter Net Profit Rose on Higher Sales
By Kimberley Kao
Chinese state-controlled oil company PetroChina said its net profit and revenue rose in the first quarter, primarily due to a rise in sales volume for its oil and gas products.
PetroChina, the listed arm of state-owned China National Petroleum Corp., said Monday that its net profit rose 4.7% from a year earlier to 45.68 billion yuan ($6.30 billion). Revenue rose 10.9% on year to CNY812.18 billion.
The Chinese oil major attributed the revenue increase primarily to higher sales volume of refined oil, natural gas and chemical products.
The group's average realized price for crude oil fell 0.8% on year to US$75.41 a barrel in the first quarter, the company said.
The demand for domestic refined oil continued to increase, it said, while natural gas also maintained "rapid growth momentum."
Another major Chinese oil producer, Cnooc, reported higher net profit and revenue in the first quarter amid higher realized prices of oil and gas products and increased sales volume.
Write to Kimberley Kao at kimberley.kao@wsj.com
(END) Dow Jones Newswires
April 29, 2024 05:27 ET (09:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact
-
Tariffs On Chinese EVs Offer US Automakers a Chance to Capture Demand
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?